Celularity Inc
CELUW
12 hedge funds and large institutions have $95.8K invested in Celularity Inc in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more capital invested
Capital invested by funds: $47.8K → $95.8K (+$48K)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.54% less ownership
Funds ownership: 11.58% → 11.04% (-0.54%)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| 1 |
PA
Procyon Advisors
Shelton,
Connecticut
|
+$620 |
| 2 |
TSS
Two Sigma Securities
New York
|
+$352 |
Top Sellers
| 1 |
Walleye Capital
New York
|
-$4.67K |
| 2 |
SC
Shay Capital
New York
|
-$2.57K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$39 |
| 4 |
CS
Clear Street
New York
|
-$11 |
CELUW Hedge Fund Activity: Q1 2025 in Review
12 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Celularity Inc (CELUW) for Q1 2025, worth a combined $95.8K — up 100% from $47.8K a quarter earlier.
Fund positioning in CELUW was balanced in Q1 2025: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Procyon Advisors, opening a new position worth an estimated $620. The largest seller was Walleye Capital, cutting an estimated $4.67K.
- 12 institutional investors held Celularity Inc (CELUW) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $95.8K of Celularity Inc stock for Q1 2025, up 100% quarter-over-quarter.
- 1 fund opened new Celularity Inc positions in Q1 2025 and 1 closed out, a net change of 0 holders.
- The largest Celularity Inc buyer in Q1 2025 was Procyon Advisors, an estimated $620 added.
- The largest Celularity Inc seller in Q1 2025 was Walleye Capital, an estimated $4.67K sold.
Based on aggregated 13F filings for Q1 2025.